N/A N=35 Vitreous Inflammation in Standard and Heavy Silicone Oil
Vitreous Inflammation
Primary: Vitreous Prostaglandin E2 Levels — 369.38; 869.16 pg/mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=122 Clinical Evaluation of Metal Panel Allergens: Dose Response Study
Dermatitis, Eczematous
Primary: Number of Participants With Patch Test Responses — 0; 105; 16; 0 Participants
N/A N=50 BioFiber Scaffold Post-Market Observational Study
Full Thickness Rotator Cuff Tear
Primary: Number of Participants With Device Associated Adverse Events — 4 Participants
N/A N=10 Magnet for Corneal Foreign Bodies
Corneal Foreign Body
Primary: Success Rate — 1 Participants
Early Phase 1 N=17 Characterization of Tissue-Specific Immune Responses to Bronchoscopic Instillation of Mycobacterial Antigens Into the Human Lung
Healthy · Latent Tuberculosis Infection (LTBI)
Primary: Median Difference in CD4 Cell Response to Intrabronchial Instillation of Tuberculin Purified Protein Derivative (PPD) — 5.26; 0.725; 29.9; 2.92 % Antigen Specific T…
N/A N=207 TiLoop® Bra for Breast Reconstruction
Patient and Surgical Related Risk Factors for Complications
Primary: Participants Who Received TiLOOP Mesh Reconstruction — 207 Patients with TiLOOP mesh reconstruction
N/A N=30 Plasma of Argon Cleaning on Implant Abutments: 5-year Results of a Randomized Clinical Trial
Endosseous Dental Implant Failure · Alveolar Bone Loss
Primary: Success Rate of the Implants and Prostheses (Participants). — 100; 100 percentage of participants — p=<0.05
N/A N=22 Peri-Implant Healing Around Two Different Machined-Collar Designs After 25 Years of Function
Jaw, Edentulous
Primary: Comparison of Distance Between First Bone to Implant Contact Point (fBIC) and Microgap (MG), After 25 Years of Function, Between All B, All SW, and All SC Dental Implant…
N/A N=6 Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer
Non-small Cell Lung Cancer Stage I
Primary: Examine the T-cell Receptor Profile Changes Induced in the Tumor After SABR
N/A N=49 FOB in HSCT and Leukemia Patients With Acute Respiratory Symptoms and Pulmonary Infiltrates
Pulmonary Infiltrate New
Primary: Number of Patients With Positive Culture or Molecular Results After Brochoscopy — 40 participants
N/A N=55 CTAG Dissection/Trauma Post Marketing Surveillance Japan
Thoracic Aortic Aneurysm · Thoracic Aorta Injury · Thoracic Aortic Dissection
Primary: Primary Entry Tear Exclusion — 21; 26; 27; 22 Participants
N/A N=34 SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery
Subjects Requiring Revision Breast Augmentation Surgery
Primary: Reoperation Rate (Per Implanted Breast) for the Presenting Condition at 12 Months. — 0; 0 Implanted breasts
N/A N=90 Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction
Breast Cancer
Primary: Number of Participants With Complications After Tissue Expander Replacement With Implant — 10; 10 participants
Phase 2 N=40 Inhaled Tissue Plasminogen Activator for Acute Plastic Bronchitis
Plastic Bronchitis · Protein-Losing Enteropathies · Healthy
Primary: Primary Endpoint: Number of Subjects That Develop New, Active Bleeding — 0 Participants
N/A N=102 Wound Healing Following Tooth Extraction and Ridge Preservation Using DFDBA Alone in Particulate Fiber Form and in Combination With Xenograft
Dental Extraction · Wound Heal
Primary: Percentage Vital Bone Formation — 37.33; 40.76; 24.46; 23.85 percentage of vital bone formation
N/A N=503 Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
Correction of Nasolabial Folds
Primary: Incidence of Device-related Adverse Events — 3 Participants
N/A N=51 CopiOs® Pericardium Membrane for Localized Alveolar Ridge Augmentation
Alveolar Ridge Defect
Primary: Change in Horizontal Ridge Widths From Baseline to 6 Months — 2.61 mm
N/A N=40 Ridge Preservation With Platelet Rich Fibrin Augmented With Freeze Dried Bone Allograft
Alveolar Ridge Preservation
Primary: Percentage of Vital Bone — 46; 39; 29; 40 percentage of vital bone
Phase 2 N=18 Biomarkers of Irritant-Induced and Allergic Asthma
Asthma
Primary: Change in TSLP Gene Expression — 0.000197; 0.000035 Fold Change
Phase 4 N=17 Treatment of Post-Extraction Dehisced Socket - A Case Series Study
Tooth Loss
Primary: Bone Volumetric Reduction From Baseline to 20 Weeks Post-extraction — 73.26 mm3